Filtered By:
Source: European Review for Medical and Pharmacological Sciences
Condition: Hemorrhagic Stroke
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 133 results found since Jan 2013.
Effect of tirofiban in treating patients with progressive ischemic stroke
CONCLUSIONS: Tirofiban combined with conventional basic treatment can greatly improve neurological deficits and disease outcomes, alleviate platelet adhesion, and reduce platelet activation without increasing the risk of hemorrhage in PIS patients.PMID:35363359 | DOI:10.26355/eurrev_202203_28357
Source: European Review for Medical and Pharmacological Sciences - April 1, 2022 Category: Drugs & Pharmacology Authors: N Du L-X Wang Y-L Liu X-L Yin J-S Zhao L Yang Source Type: research
Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI
CONCLUSIONS: Our study indicates the efficacy and safety of low-dose rTPA treatment for AIS without LVO within 4.5 hours. Patient selection for rTPA by 3T MRI decreased complications and mortality.PMID:37522667 | DOI:10.26355/eurrev_202307_33126
Source: European Review for Medical and Pharmacological Sciences - July 31, 2023 Category: Drugs & Pharmacology Authors: Q-S Huynh C-C Tran H-T Nguyen-Thi T-T Nguyen H-L Phan-Thi D-T Luu-Dang M-T Le M-D Nguyen Source Type: research
